Guidelines and recommendations screened
ACOE, Accreditation Council for Oncology in Europe; ACS/CoC, American College of Surgeons/Commission on Cancers; BCSH, British Committee for Standards in Haematology; BMT-CTN, Blood and Marrow Transplant Clinical Trials Network; CMML, Chronic myelomonocytic leukemia; DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie; DKG, Deutsche Krebs Gesellschaft; EBMT, European Society for Blood and Marrow Transplantation; ELN, European Leukemia Net; ESMO, European Society of Medical Oncology; FISiM, Fondazione Italiana Syndromi Mielodysplastice; GESMD, Groupo Espanol De Sindromes Mielodisplasticos; GFM, Groupe Francophone des Myelodysplasies; HOVON, Hemato Oncology Foundation for Adults in The Netherlands; NCCN, National Comprehensive Cancer Network; NICE, National Institute for Health and Care; NMDSG, Nordic MDS Study Group; OECI, Organization of European Cancer Institutes; OeGHO, Österreichische Gesellschaft für Hämatologie und Onkologie; SCN, Swiss Cancer Network; SGH-SSH, Swiss Society for Hematology; UK, United Kingdom; USA, United States of America.